CGON
CG Oncology, Inc. Common stock
NASDAQ · Healthcare · Biotechnology · US
$74.67
+0.46%Aug 6, 2026, 12:15 UTC
CG Oncology, Inc. reported its financial results for the second quarter ended June 30, 2026.
Source:Jul 16, 2026, 20:34 UTC
ANI Pharmaceuticals announces its intent to appeal the denial of its post-trial motions in the CG Oncology matter to the Delaware Supreme Court.
Source: